Cantor Fitzgerald restated their overweight rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $50.00 target price on the stock. Several other research analysts have also recently issued reports on the company. Wells Fargo & Company increased their price objective on […]